Clinical trials are underway (NCT04674813, NCT05016778, NCT05739188, NCT05749133, NCT06084962, NCT05759793, NCT05219721) to assess autologous CAR T-cells targeting GPRC5D in R/R MM patients [88, 89, 94]. This evidence concerns the gene GPRC5D and Miyoshi myopathy.